Tecan Group AG | Cash Flow

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
45,671.00
40,216.00
57,147.00
54,542.00
66,547.00
70,696
Depreciation, Depletion & Amortization
10,259.00
10,339.00
16,452.00
20,894.00
23,692.00
21,769
Other Funds
-
-
-
1,947.00
-
6,179
Funds from Operations
65,543.00
61,416.00
75,904.00
90,674.00
104,039.00
102,479
Changes in Working Capital
37,703.00
13,315.00
23,176.00
28,183.00
4,864.00
10,134
Net Operating Cash Flow
27,840.00
48,101.00
99,080.00
118,857.00
99,175.00
92,345
Capital Expenditures
19,777.00
22,629.00
14,723.00
14,322.00
19,641.00
Sale of Fixed Assets & Businesses
85.00
227.00
73.00
76.00
98.00
Net Investing Cash Flow
19,837.00
54,356.00
33,549.00
54,555.00
22,438.00
Cash Dividends Paid - Total
16,488.00
16,651.00
16,857.00
20,122.00
20,315.00
Issuance/Reduction of Debt, Net
3,682.00
2,446.00
2,256.00
7,837.00
3,216.00
Net Financing Cash Flow
2,050.00
15,710.00
14,831.00
26,005.00
14,876.00
Net Change in Cash
5,857.00
21,662.00
79,719.00
38,310.00
62,668.00
Free Cash Flow
20,643.00
42,785.00
94,406.00
112,077.00
91,033.00
Net Assets from Acquisitions
145.00
31,954.00
18,899.00
40,309.00
2,895.00
Change in Capital Stock
10,756.00
3,387.00
33,944.00
7.00
3,369.00
Exchange Rate Effect
96.00
303.00
643.00
13.00
807.00

About Tecan Group

View Profile
Address
Seestrasse 103
Maennedorf Zurich 8708
Switzerland
Employees -
Website http://www.tecan.com
Updated 07/08/2019
Tecan Group AG is a holding company, which engages in the development, production, and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. It operates through the Life Sciences Business and Partnering Business segments. The Life Sciences Business segment supplies end users with automated workflow solutions, which includes laboratory instruments, software packages, application know-how, services, consumables, and spare parts.